Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers: A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview by Mukesh Nandave
eBook[PDF]

Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers: A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview by Mukesh Nandave

$39.00
✓ Secure checkout
✓ Instant digital download
✓ PDF document

Document details

Pages
609
File size
7.56 MB
Format
Digital PDF
Course
Medicine
Category
eBook[PDF]
About this ebook
The book Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers: A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview by Mukesh Nandave covers several core scientific and clinical areas regarding the renin-angiotensin-aldosterone system (RAAS) and cardiovascular medicine. [1]
According to the official publisher details from sources like SpringerLink and Barnes & Noble, the specific topics and chapters covered in this literature overview include:
  • RAAS Overview: An in-depth introduction to the renin-angiotensin-aldosterone system and how these drugs exert antihypertensive effects.
  • Cardiovascular Disorders: The role of these antihypertensive agents in reducing cardiovascular morbidity and mortality, including coronary artery disease, stroke, and heart failure.
  • High-Risk Patients: A critical comparison evaluating the preferred use of ACE inhibitors over ARBs, alongside the relative advantages and disadvantages of each class.
  • Insulin Resistance: The metabolic impact of these agents and their specific influence on insulin sensitivity.
  • Acute Heart Failure: The clinical role and management strategies of RAAS inhibitors during acute heart failure episodes.
  • Peripheral Artery Disease: The therapeutic application and outcomes of using these medications for peripheral vascular conditions.
  • Immunomodulatory Activity: Exploration of how these medications affect immune responses and inflammation in hypertensive patients.
  • COVID-19 Management: The specific role, outcomes, and implications of using ACE inhibitors and ARBs in patients infected with COVID-19.
  • Recent Hypertension Trends: Insightful data on current and emerging global clinical trends in managing hypertension via RAAS inhibition. [1, 2]

File included

PDF
Angiotensin-converting_Enzyme_Inhibitors_vs_Angiotensin_Receptor_Blockers_Nandave_1_ed_2024.pdf 7.56 MB

Topics

A Critical Analysis of Antihypertensive Strategies A Machine-Generated Literature Overview Acute Heart Failure Angiotensin Receptor Blockers Angiotensin-converting Enzyme Inhibitors Angiotensin-converting Enzyme Inhibitors vs. Angio Cardiovascular Disorders COVID-19 Management: The specific role outcomes High-Risk Patients evaluating the preferred use of ACE inhibitors over ARBs Immunomodulatory Activity Insulin Resistance: The metabolic impact of these agents managing hypertension via RAAS inhibitio Peripheral Artery Disease RAAS Overview introduction to the renin-angiotensin-aldosterone system Recent Hypertension Trends role of these antihypertensive agents in reducing cardiovascular morbidity and mortality The clinical role and management strategies of RAAS inhibitors during acute heart failure episodes. The therapeutic application and outcomes of using these medications for peripheral vascular conditions. using ACE inhibitors and ARBs in patients infected with COVID-19.
Related ebooks